Securities code: 688575 securities abbreviation: Shenzhen Yhlo Biotech Co.Ltd(688575) Announcement No.: 2022-004 Shenzhen Yhlo Biotech Co.Ltd(688575)
Announcement of resolutions of the third meeting of the third board of supervisors
The board of supervisors and all supervisors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear legal liabilities for the authenticity, accuracy and integrity of its contents according to law.
Shenzhen Yhlo Biotech Co.Ltd(688575) (hereinafter referred to as “the company”) the third meeting of the third board of supervisors (hereinafter referred to as “the meeting”) was held on January 14, 2022 in the form of on-site communication. Three supervisors should attend the meeting, and three actually attended the meeting, accounting for 100% of the number of supervisors who should attend. The convening and convening procedures of this meeting meet the requirements of the articles of association and relevant laws and regulations. After deliberation and voting by the supervisors present at the meeting, the following resolutions were reached at the meeting:
1、 The proposal on the company’s restricted stock incentive plan in 2022 (Draft) and its summary was deliberated and adopted
The company’s restricted stock incentive plan for 2022 (Draft) and its abstract comply with the company law of the people’s Republic of China, the securities law of the people’s Republic of China, the measures for the administration of equity incentive of listed companies, the Listing Rules of the Shanghai Stock Exchange on the Kechuang board, and the self regulatory guide for listed companies on the Kechuang board No. 4 – disclosure of equity incentive information And other relevant laws, regulations, normative documents and the articles of association. The implementation of this incentive plan will be conducive to the sustainable development of the company, and there will be no damage to the interests of the company and all shareholders. Therefore, the board of supervisors unanimously agreed to implement the restricted stock incentive plan in 2022.
For details, please refer to the website of Shanghai Stock Exchange on the same day (www.sse. Com. CN.) The Shenzhen Yhlo Biotech Co.Ltd(688575) 2022 restricted stock incentive plan (Draft) and its abstract disclosed on the.
Voting result: 3 votes in favor; 0 votes against; There were no abstentions.
This proposal needs to be submitted to the general meeting of shareholders for deliberation.
2、 The proposal on the management measures for the implementation and assessment of the company’s restricted stock incentive plan in 2022 was deliberated and adopted
The company’s management measures for the assessment of the implementation of restricted stock incentive plan in 2022 comply with the provisions of relevant laws and regulations and the actual situation of the company, which can ensure the smooth implementation of the company’s restricted stock incentive plan in 2022, further improve the corporate governance structure and form a good and balanced value distribution system, Establish a benefit sharing and restraint mechanism between shareholders and employees of the company. Therefore, the board of supervisors unanimously agreed to this proposal.
For details, please refer to the website of Shanghai Stock Exchange on the same day (www.sse. Com. CN.) Measures for the administration of Shenzhen Yhlo Biotech Co.Ltd(688575) 2022 restricted stock incentive plan implementation assessment disclosed in the.
Voting result: 3 votes in favor; 0 votes against; There were no abstentions.
This proposal needs to be submitted to the general meeting of shareholders for deliberation.
3、 The proposal on verifying the list of incentive objects granted for the first time by the company’s restricted stock incentive plan in 2022 was deliberated and adopted
The personnel listed in the list of incentive objects granted for the first time in the company’s incentive plan have the qualifications specified in the company law of the people’s Republic of China and other laws, regulations, normative documents and the articles of association, and there is no situation that they have been identified as inappropriate candidates by the stock exchange in the last 12 months; There is no case that the CSRC and its dispatched offices have identified it as an inappropriate candidate within the last 12 months; There are no cases in which the CSRC and its dispatched offices have imposed administrative penalties or taken market entry prohibition measures for major violations of laws and regulations in the last 12 months; There is no circumstance that the company is not allowed to serve as a director or senior manager of the company as stipulated in the company law; There are no circumstances where the company is not allowed to participate in the equity incentive of listed companies according to laws and regulations, meet the conditions of incentive objects specified in the administrative measures for equity incentive of listed companies and the Listing Rules of science and Innovation Board of Shanghai Stock Exchange, and meet the scope of incentive objects specified in the company’s incentive plan and its summary, As the subject qualification granted to the incentive object for the first time in the incentive plan of the company, it is legal and effective.
The company will publicize the names and positions of incentive objects within the company through the company’s website or other channels before the general meeting of shareholders, and the publicity period shall not be less than 10 days. The board of supervisors will disclose the audit opinions on the list of incentive objects and the explanation of their publicity five days before the shareholders’ meeting considers the equity incentive plan.
Voting result: 3 votes in favor; 0 votes against; There were no abstentions.
It is hereby announced.
Shenzhen Yhlo Biotech Co.Ltd(688575) board of supervisors January 15, 2022
